Journal of Hematology

Editor-in-Chief
Farhad Ravandi, MD, Professor
Janiece and Stephen A. Lasher Professor of Medicine
Chief, Section of Acute Myeloid Leukemia
Department of Leukemia
The University of Texas MD Anderson Cancer Center, Texas, USA  Read more...

ISSN 1927-1212 print | ISSN 1927-1220 online | Bimonthly | Open Access | Aims and Scope

Indexed and covered by: Chemical Abstract (CA); Worldcat; Google; Google Scholar; JournalTOCs; PubMed Central; PubMed; Web of Science, JCR Impact Factor 2023: 1.3

 Journal archiving and digital preservation: Portico


Highlights

  • Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis

    Treatment with non-anthracycline (ANT)-based chemotherapy has increased survival in patients with extranodal natural killer/T-cell lymphoma (ENKTCL). However, the relative efficacy of various drug combinations has been contentious.

    Read More >>
  • Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma

    Diffuse large B-cell lymphoma (DLBCL) is a heterogenous hematological disorder with malignant potential controlled by immunological characteristics of the tumor microenvironment. Rapid breakthrough in the molecular pathways has made immunological approaches the main anchor in the management of DLBCL, with or without chemotherapeutic agents.

    Read More >>
  • Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis

    Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy. ICI therapy is generally better tolerated than cytotoxic chemotherapy; however, hematological adverse events (AEs) have not been fully analyzed.

    Read More >>
  • Mature Type T-Lymphoblastic Leukemia/Lymphoma Presenting With Isolated Central Nervous System Symptomatology in a Patient With Giant Cell Arteritis on Long-Term Steroid Treatment

    T-lymphoblastic leukemia/lymphoma (T-ALL/T-LBL) is a malignancy comprised of T-lymphoblasts that can present as one of four clinical subtypes (pro-T, pre-T, cortical T, and mature T).

    Read More >>
  • Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies

    Acute myeloid leukemia (AML) arising from myeloproliferative neoplasms (MPNs) represents a small subtype of secondary AML (sAML). This entity is well known to be associated with poor responses to available treatment options and dismal outcomes.

    Read More >>
< >

Featured

 

 

Featured

 

Real-World Data of Crizanlizumab in Sickle Cell Disease: A Single-Center Analysis
 Crizanlizumab was approved by the United States Food and Drug Administration agency in 2019 for decreasing vaso-occlusive events (VOEs) in sickle cell disease (SCD). Data regarding the use of crizanlizumab in the real-world setting are limited. Full Text

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
 Patients with chronic lymphocytic leukemia (CLL) are vulnerable to coronavirus disease 2019 (COVID-19) and are at risk of inferior response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, especially if treated with the first-generation Bruton’s tyrosine kinase inhibitor (BTKi) ibrutinib. Full Text


Key Clinical Image

Sickle Cell Trait: Is It Always Benign?
Sickle cell disease is a well-known homozygous inherited hemoglobinopathy that causes vaso-occlusive phenomena and chronic hemolysis. Vaso-occlusion results in sickle cell crisis and can eventually lead to complications involving multiple organ systems. However, the heterozygous counterpart, sickle cell trait (SCT) has less clinical significance as these patients are generally asymptomatic. Full Text


Current Issue

 

Vol. 13, No. 3, Jun 2024

Table of Contents

Review

Sickle Cell Screening in Adults: A Current Review of Point-of-Care Testing Abstract HTML PDF
Sebastian R. Mendez-Marti, Chad Zik, Sheinei Alan, Hongkun Wang, William B. Ershler 53-60
doi: https://doi.org/10.14740/jh1272
Acquired Aplastic Anemia Therapies: Immunosuppressive Therapy Versus Alternative Donor Hematopoietic Cell Transplantation Abstract HTML PDF
Baldeep Wirk 61-70
doi: https://doi.org/10.14740/jh1264

Original Article

Predictors of Non-Variceal Hemorrhage in a National Cohort of Patients With Chronic Liver Disease Abstract HTML PDF Suppl1 Suppl2 Suppl3
Amber Afzal, Preethi Kesavan, Luo Suhong, Brian F. Gage, Kevin Korenblat, Martin Schoen, Kristen Sanfilippo 71-78
doi: https://doi.org/10.14740/jh1214
Steady-State Versus Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma: A Single-Center Study to Analyze Efficacy and Safety Abstract HTML PDF
Nora Obajed Al-Ali, Laszlo Imre Pinczes, Katalin Farkas, Gyorgy Kerekes, Arpad Illes, Laszlo Varoczy 79-85
doi: https://doi.org/10.14740/jh1256

Short Communication

Frameshift Mutations in Leukemia-Associated Genes Correlate With Superior Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant for De Novo Acute Myeloid Leukemia Abstract HTML PDF Suppl1
Emma Cammann, Sindha Madhav, Lloyd Hutchinson, Jan Cerny, Muthalagu Ramanathan, Jacob R. Bledsoe, Vladislav Makarenko, Shyam A. Patel, Xiuling Meng, Keith Tomaszewicz, Rajneesh Nath, Benjamin Chen, Bruce Woda, William Selove 86-93
doi: https://doi.org/10.14740/jh1276

Case Report

Non-Secretory Multiple Myeloma Associated With High-Risk Phenotype and Complex Cytogenetics Including t(8;22) Abstract HTML PDF
Rahim A. Jiwani, Joseph R. Liput, Attah Abraham, Khaled Alhamad, Mukta Kapdi, Renan Mota, Kayla Forte, John R. McGill, Jasper C. Acer, Palgun Nisarga, Nicholas R. Jaeger, Santhosh Sadashiv, Prerna Mewawalla 94-98
doi: https://doi.org/10.14740/jh1248
A Hemoglobinopathy That Produces an Array of Different Hemoglobin A1c Values Abstract HTML PDF
Maximo J. Marin, Bremansu Osa-Andrews, Patrick A. Maher, Clive Wasserfall, William E. Winter, Ashraf B. Muzwagi, Neil S. Harris 99-103
doi: https://doi.org/10.14740/jh1268
Fat Embolism Syndrome Mimicking Thrombotic Thrombocytopenic Purpura in a Patient With Hemoglobin S/Beta-Thalassemia Abstract HTML PDF
Bobby Se, Austin Frisch, Min Woo Hwang, Faran Polani, Najeebah Bade 104-107
doi: https://doi.org/10.14740/jh1274
Characterization and Clinical Assessment of a Peculiar Case of Hemolytic Anemia Abstract HTML PDF
Fulvio Castelgrande, Gemma Viola, Cinzia Calabrese, Mariannina Iozzo, Renato Massoud, Massimo Pieri, Marilena Minieri, Gaspare Adorno, Sergio Bernardini, Alessandro Terrinoni 108-115
doi: https://doi.org/10.14740/jh1204
A Unique Case of a Compound Heterozygosity of Hemoglobin Korle-Bu and Sickle Cell Trait in a Military Trainee Abstract HTML PDF
Gartrell C. Bowling, Niels A. Ryden, Allen R. Holmes, Lauren E. Lee, Kristin Stoll 116-120
doi: https://doi.org/10.14740/jh1257
Recurrent Infection in a Young Female Patient Recently Diagnosed With Primary Evans Syndrome Without Neutropenia Abstract HTML PDF
Jennie An, Preye Amaruntowa, Waleed Ahmed, Ali Khan, Muhammad Shahzad 121-124
doi: https://doi.org/10.14740/jh1265
Venous Thromboembolism Following COVID-19 Vaccination in Patients With Hereditary Protein S Deficiency Abstract HTML PDF
Molly Rayner, Kelsey Brose 125-127
doi: https://doi.org/10.14740/jh1278
Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis Abstract HTML PDF
Ruah Alyamany, Chams Alkhalaf Albachir, Sarah Alsaleh, Alaa Hamad, Sameeha Kaiser Abdulwali, Ahmad S. Alotaibi, Syed Osman Ahmed, Mansour Alfayez 128-136
　

Browse  Journals  

     

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 
 

Journal of Hematology, bimonthly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.                            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.